Erythromycin/sulfafurazole
(Redirected from Erythromycin/Sulfafurazole)
| Combination of | |
|---|---|
| Erythromycin | Macrolide antibiotic |
| Sulfafurazole | Sulfonamide antibiotic |
| Clinical data | |
| Trade names | Pediazole |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
Erythromycin/sulfafurazole (trade name Pediazole) is a combination drug with the antibiotics erythromycin and sulfafurazole (the latter is also known as sulfisoxazole).[citation needed]
It is indicated in acute otitis media in children, particularly when Hemophilus influenzae is the suspected pathogen.[1]
References
- ^ erythromycin base/sulfisoxazole at Medscape. Retrieved April 29, 2013. Patient handout: [1].
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All articles with unsourced statements
- Articles with unsourced statements from February 2023
- Combination antibiotics
- Antibiotics
- All stub articles
- Pharmacology stubs